187 related articles for article (PubMed ID: 27793710)
21. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery.
Cano-Cebrián MJ; Zornoza T; Granero L; Polache A
Curr Drug Deliv; 2005 Jan; 2(1):9-22. PubMed ID: 16305404
[TBL] [Abstract][Full Text] [Related]
22. Absorption and safety of alendronate, a nitrogen-containing bisphosphonate, after intrapulmonary administration in rats.
Katsumi H; Nakatani M; Sano J; Abe M; Kusamori K; Kurihara M; Shiota R; Takashima M; Fujita T; Sakane T; Hibi T; Yamamoto A
Int J Pharm; 2010 Nov; 400(1-2):124-30. PubMed ID: 20816731
[TBL] [Abstract][Full Text] [Related]
23. Absorption enhancing effects of chitosan oligomers on the intestinal absorption of low molecular weight heparin in rats.
Zhang H; Mi J; Huo Y; Huang X; Xing J; Yamamoto A; Gao Y
Int J Pharm; 2014 May; 466(1-2):156-62. PubMed ID: 24614577
[TBL] [Abstract][Full Text] [Related]
24. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
Yamamoto A; Tatsumi H; Maruyama M; Uchiyama T; Okada N; Fujita T
J Pharmacol Exp Ther; 2001 Jan; 296(1):84-90. PubMed ID: 11123366
[TBL] [Abstract][Full Text] [Related]
25. Effects of fatty acid sucrose esters on ceftibuten transport by rat intestinal brush-border membrane vesicles.
Koga K; Murakami M; Kawashima S
Biol Pharm Bull; 1998 Jul; 21(7):747-51. PubMed ID: 9703261
[TBL] [Abstract][Full Text] [Related]
26. Enhanced Intestinal Absorption of Insulin by Capryol 90, a Novel Absorption Enhancer in Rats: Implications in Oral Insulin Delivery.
Ukai H; Iwasa K; Deguchi T; Morishita M; Katsumi H; Yamamoto A
Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32443624
[TBL] [Abstract][Full Text] [Related]
27. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
[TBL] [Abstract][Full Text] [Related]
28. [Improvement of intestinal absorption of poorly absorbable drugs by polyamidoamine (PAMAM) dendrimers as novel absorption enhancers].
Yamamoto A
Yakugaku Zasshi; 2010 Sep; 130(9):1123-7. PubMed ID: 20823669
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic Studies on the Absorption-Enhancing Effects of Gemini Surfactant on the Intestinal Absorption of Poorly Absorbed Hydrophilic Drugs in Rats.
Alama T; Kusamori K; Morishita M; Katsumi H; Sakane T; Yamamoto A
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30959978
[TBL] [Abstract][Full Text] [Related]
30. The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats.
Hamid KA; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2009 Sep; 379(1):100-8. PubMed ID: 19555752
[TBL] [Abstract][Full Text] [Related]
31. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies.
McCartney F; Jannin V; Chevrier S; Boulghobra H; Hristov DR; Ritter N; Miolane C; Chavant Y; Demarne F; Brayden DJ
J Control Release; 2019 Sep; 310():115-126. PubMed ID: 31401199
[TBL] [Abstract][Full Text] [Related]
32. Application of sucrose fatty acid esters in transdermal therapeutic systems.
Csóka G; Marton S; Zelko R; Otomo N; Antal I
Eur J Pharm Biopharm; 2007 Feb; 65(2):233-7. PubMed ID: 16963242
[TBL] [Abstract][Full Text] [Related]
33. EICOSAPENTAENOIC ACID ENHANCES HEATSTROKE-IMPAIRED INTESTINAL EPITHELIAL BARRIER FUNCTION IN RATS.
Xiao G; Yuan F; Geng Y; Qiu X; Liu Z; Lu J; Tang L; Zhang Y; Su L
Shock; 2015 Oct; 44(4):348-56. PubMed ID: 26131715
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of 14C-labelled sucrose esters of stearic acid in rats.
Noker PE; Lin TH; Hill DL; Shigeoka T
Food Chem Toxicol; 1997 Jun; 35(6):589-95. PubMed ID: 9225017
[TBL] [Abstract][Full Text] [Related]
35. Studies on the metabolic fate of sucrose esters in rats.
Shigeoka T; Izawa O; Kitazawa K; Yamauchi F; Murata T
Food Chem Toxicol; 1984 Jun; 22(6):409-14. PubMed ID: 6539729
[TBL] [Abstract][Full Text] [Related]
36. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
37. Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae.
McCartney F; Perinelli DR; Tiboni M; Cavanagh R; Lucarini S; Filippo Palmieri G; Casettari L; Brayden DJ
Int J Pharm; 2021 May; 601():120593. PubMed ID: 33857587
[TBL] [Abstract][Full Text] [Related]
38. Tight junction modulation and its relationship to drug delivery.
Salama NN; Eddington ND; Fasano A
Adv Drug Deliv Rev; 2006 Apr; 58(1):15-28. PubMed ID: 16517003
[TBL] [Abstract][Full Text] [Related]
39. Spiral progression in the development of absorption enhancers based on the biology of tight junctions.
Kondoh M; Takahashi A; Yagi K
Adv Drug Deliv Rev; 2012 May; 64(6):515-22. PubMed ID: 21802464
[TBL] [Abstract][Full Text] [Related]
40. Intestinal permeation enhancers for oral peptide delivery.
Maher S; Mrsny RJ; Brayden DJ
Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
